Panbela Therapeutics, Inc.
PBLA
$0.2603
-$0.0607-18.91%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.73M | 59.00K | 262.00K | 2.58M | 907.00K |
| Total Receivables | 332.00K | 320.00K | 313.00K | 183.00K | 155.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 109.00K | 393.00K | 1.21M | 299.00K | 824.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 5.17M | 772.00K | 1.79M | 3.06M | 1.89M |
|
|
|||||
| Total Current Assets | 5.17M | 772.00K | 1.79M | 3.06M | 1.89M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 8.64M | 8.74M | 8.74M | 8.74M |
| Total Assets | 5.17M | 9.41M | 10.53M | 11.80M | 10.63M |
|
|
|||||
| Total Accounts Payable | 10.95M | 14.29M | 8.51M | 9.94M | 6.61M |
| Total Accrued Expenses | 5.99M | 1.50M | 1.01M | 1.38M | 1.31M |
| Short-term Debt | 2.20M | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.00M | 1.00M | 1.00M | 1.00M | 1.00M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 20.14M | 16.79M | 10.52M | 12.32M | 8.92M |
|
|
|||||
| Total Current Liabilities | 20.14M | 16.79M | 10.52M | 12.32M | 8.92M |
| Long-Term Debt | 3.19M | 3.19M | 3.19M | 4.19M | 4.19M |
| Short-term Debt | 2.20M | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 23.34M | 19.98M | 13.71M | 16.51M | 13.11M |
|
|
|||||
| Common Stock & APIC | 128.23M | 128.23M | 128.23M | 120.04M | 106.03M |
| Retained Earnings | -146.94M | -139.76M | -132.62M | -125.50M | -109.88M |
| Treasury Stock & Other | 540.00K | 961.00K | 1.20M | 744.00K | 1.37M |
| Total Common Equity | -18.17M | -10.57M | -3.19M | -4.71M | -2.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.17M | -10.57M | -3.19M | -4.71M | -2.48M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.17M | -10.57M | -3.19M | -4.71M | -2.48M |
|
|
|||||